Status: Not yet recruiting
CAN1012 in Pre-Malignant DCIS and LCIS
This is a Phase I/Ib study evaluating CAN1012 in patients with ductal carcinoma in situ and lobular carcinoma in situ.
Participants needed: 24
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Providence Health & ServicesUpdated: Apr 8, 2026Locations: 1
Eligibility criteria
Male or female patients with DCIS or LCIS found on core biopsy. [+10]
Any serious underlying medical or psychiatric condition that, in the opinion of... [+9]